Cargando…
Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050270/ https://www.ncbi.nlm.nih.gov/pubmed/35493299 http://dx.doi.org/10.1155/2022/2008556 |
_version_ | 1784696324078174208 |
---|---|
author | Li, Zhi-Zhao Huang, Qiong Yang, Xiao-li Zeng, Jieqiong Wang, QI-Hui Tang, Hai-Ming Yu, Zhen-qiu Song, Yu-Qing Liu, Yang |
author_facet | Li, Zhi-Zhao Huang, Qiong Yang, Xiao-li Zeng, Jieqiong Wang, QI-Hui Tang, Hai-Ming Yu, Zhen-qiu Song, Yu-Qing Liu, Yang |
author_sort | Li, Zhi-Zhao |
collection | PubMed |
description | The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of 69 hyperlipidemia patients, 25 familial hypercholesteremia (FHC) patients, and 64 healthy controls were enrolled in this study. We performed routine testing of blood lipid water. Gas chromatography was used to determine the changes in the concentration of cholesterol synthesis (squalene, desmosterol, and lathosterol) and absorption markers (campesterol, sitosterol, and stigmasterol) in the blood. Baseline hyperlipidemia patients displayed significantly higher total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels in comparison to the control group, which was reflected in the increased levels of squalene, desmosterol, campesterol, and sitosterol observed (P < 0.05) in the hyperlipidemia patients. The desmosterol, lathosterol, campesterol, stigmasterol, and sitosterol were statistically different in the FHC group than the hyperlipidemic group (P < 0.05). The proportions of squalene/cholesterol, lathosterol/cholesterol, stigmasterol/cholesterol, and sitosterol/cholesterol in the FHC group were lower than those in the hyperlipidemic group; only desmosterol/cholesterol was higher than that in the hyperlipidemic group. Correlation studies between lipid metabolic factors showed that the proportion of moderate and strong correlations was much higher in the FHC group than in the other two groups (76.92% vs. 32.50% and 31.25%). Logistic regression analysis showed that the concentrations of glucose, LDL-C, lactosterol, and sitosterol were all independent risk factors for developing hyperlipidemia. This result was further confirmed by the ROC curve. These results indicated that the study of cholesterol synthesis and decomposition markers can serve as a reference index for related diseases caused by changes in its concentration. |
format | Online Article Text |
id | pubmed-9050270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-90502702022-04-29 Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia Li, Zhi-Zhao Huang, Qiong Yang, Xiao-li Zeng, Jieqiong Wang, QI-Hui Tang, Hai-Ming Yu, Zhen-qiu Song, Yu-Qing Liu, Yang Dis Markers Research Article The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of 69 hyperlipidemia patients, 25 familial hypercholesteremia (FHC) patients, and 64 healthy controls were enrolled in this study. We performed routine testing of blood lipid water. Gas chromatography was used to determine the changes in the concentration of cholesterol synthesis (squalene, desmosterol, and lathosterol) and absorption markers (campesterol, sitosterol, and stigmasterol) in the blood. Baseline hyperlipidemia patients displayed significantly higher total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels in comparison to the control group, which was reflected in the increased levels of squalene, desmosterol, campesterol, and sitosterol observed (P < 0.05) in the hyperlipidemia patients. The desmosterol, lathosterol, campesterol, stigmasterol, and sitosterol were statistically different in the FHC group than the hyperlipidemic group (P < 0.05). The proportions of squalene/cholesterol, lathosterol/cholesterol, stigmasterol/cholesterol, and sitosterol/cholesterol in the FHC group were lower than those in the hyperlipidemic group; only desmosterol/cholesterol was higher than that in the hyperlipidemic group. Correlation studies between lipid metabolic factors showed that the proportion of moderate and strong correlations was much higher in the FHC group than in the other two groups (76.92% vs. 32.50% and 31.25%). Logistic regression analysis showed that the concentrations of glucose, LDL-C, lactosterol, and sitosterol were all independent risk factors for developing hyperlipidemia. This result was further confirmed by the ROC curve. These results indicated that the study of cholesterol synthesis and decomposition markers can serve as a reference index for related diseases caused by changes in its concentration. Hindawi 2022-04-21 /pmc/articles/PMC9050270/ /pubmed/35493299 http://dx.doi.org/10.1155/2022/2008556 Text en Copyright © 2022 Zhi-Zhao Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Li, Zhi-Zhao Huang, Qiong Yang, Xiao-li Zeng, Jieqiong Wang, QI-Hui Tang, Hai-Ming Yu, Zhen-qiu Song, Yu-Qing Liu, Yang Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title | Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title_full | Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title_fullStr | Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title_full_unstemmed | Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title_short | Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia |
title_sort | cholesterol metabolic markers for differential evaluation of patients with hyperlipidemia and familial hypercholesterolemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050270/ https://www.ncbi.nlm.nih.gov/pubmed/35493299 http://dx.doi.org/10.1155/2022/2008556 |
work_keys_str_mv | AT lizhizhao cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT huangqiong cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT yangxiaoli cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT zengjieqiong cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT wangqihui cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT tanghaiming cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT yuzhenqiu cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT songyuqing cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia AT liuyang cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia |